Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Texas Diabetes and Endocrinology (TDE) is a premier medical practice and clinical research organization based in Central Texas, specializing in the diagnosis and treatment of diabetes, thyroid disorders, and other hormonal conditions. Founded in 2001 by Dr. Thomas Blevins, the company operates multiple clinics in Austin and Round Rock, providing comprehensive care including advanced lipid testing, thyroid imaging, and diabetes education. TDE's Research Department is recognized globally as a top endocrine research site, conducting Phase 2 through Phase 4 clinical trials for novel pharmaceuticals and medical devices. The practice integrates cutting-edge technology, such as continuous glucose monitors and insulin pumps, into its patient care and research protocols. TDE collaborates with major pharmaceutical sponsors like Eli Lilly and Novo Nordisk to advance therapies for cardiometabolic and endocrine diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Texas Diabetes and Endocrinology.